Lou Gehrig’s Disease Safety Signal With Statins Not Convincing
Lou Gehrig’s Disease Safety Signal With Statins Not Convincing
A joint FDA Nonprescription Drugs and Endocrinologic and Metabolic Drugs Advisory Committee said last week that there was not enough evidence of a potential link between the use of statins and the development of Lou Gehrig’s disease to warrant consideration in an approval decision regarding OTC versions of the drugs. http://fdanews.com/newsletter/articl...ticleId=102273 |
All times are GMT -5. The time now is 08:37 AM. |
Powered by vBulletin Copyright ©2000 - 2024, Jelsoft Enterprises Ltd.
vBulletin Optimisation provided by
vB Optimise v2.7.1 (Lite) -
vBulletin Mods & Addons Copyright © 2024 DragonByte Technologies Ltd.